evaluation of the sedation effect of intranasal ketamine and midazolam to perform gastric aspirates in children: a randomized, pilot study

evaluation of the sedation effect of intranasal ketamine and midazolam to perform gastric aspirates in children: a randomized, pilot study - utility of intranasal ketamine and midazolam to perform gastric aspirates in children: a pilot study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010623

Enrollment

Registered

2013-10-04

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with suspected tuberculosis who need to perform gastric aspirates for microbiological diagnosis

Interventions

- Intervention group: children receive intranasal ketamine (2 mg/kg) and midazolam (0.5 mg/kg) to perform gastric aspirates in children. - placebo: children receive 1 ml of normal salin solution in e

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children with suspected tuberculosis

Exclusion criteria

Exclusion criteria: known allergy to ketamine or benzodiazepine, ASA classification of III or higher, upper respiratory tract infection with nasal discharge, known liver disease or respiratory distress

Design outcomes

Primary

Measure	Time frame
evaluation of the sedative effect of intranasal ketamine and midazolam to perform gastric aspirates in childrn	—

Secondary

Measure	Time frame
evaluation of side effects of intranasal ketamine and midazolam to perform gastric aspirates in children: a pilot study	—

Countries

Europe

Contacts

Public Contactantonio chiaretti

Catholic University - A. Gemelli Hospital, rome, Italy Department of Pediatrics

achiaretti@yahoo.it+81-0390630154348

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026